In this article, we are going to take a look at where Immunovant, Inc. (NASDAQ:IMVT) stands against other biotech stocks with the biggest upside potential. While 2024 was a “challenging” year ...

In trading on Tuesday, shares of Immunovant Inc (Symbol: IMVT) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $15 per share. By comparison ...